Pharmacological evidence indicates that D2 dopaminergic (D2R) and A2a adenosinergic (A2aR) receptors interact to modulate motor function. Until recently little was known about the anatomical and cellular basis of this interaction between A2aR and D2R. We recently demonstrated that A2aR mRNA and D2R are exclusively co-expressed in a subset of rat striatal neurons which comprise the striatopallidal or """"""""indirect"""""""" pathway of striatal efferent neurons to the major basal ganglia output nuclei. The A2aR, therefore, is located in a potentially powerful position for modulating activity in the striatopallidal pathway. No other neurotransmitter receptor has been identified which is expressed in as influential a position to selectively regulate the response of the motor system to D2R activation. The overall hypothesis of Project 3 is that interaction between A2aRs and D2Rs occurs in an subset striatal neurons and effects changes in motor behavior by regulating activity in the """"""""indirect"""""""" striatopallidal pathway in rodents and humans. Anatomical and pharmacological evidence strongly suggests that the A2AR is of considerable importance to understanding the pathophysiology of movement disorders and the design of effective treatments. However, the cellular mechanisms by which A2aR and D2R interact to modulate motor function are not understood. Therefore, in Project 3 we propose to investigate several aspects of the biology of the A2aR particularly with reference to the human A2aR. In this Project we will characterize the (1) structure of the human A2aR gene, (2) the anatomical expression of the human A2aR gene and its protein product within the human striatum, (3) changes in activity of striatopallidal neurons in vivo resulting from interaction between A2aR and D2R, (4) the cellular mechanisms by which A2aR and D2Rs may interact to regulate activity within cells of the indirect striatal efferent pathway and (5) the mechanisms by which expression of the rat A2aR gene is regulated. These studies will provide important information about the receptor and cellular mechanisms by which A2aR and D2Rs interact to regulate motor function in human movement disorders and, possible, reveal novel approaches for regulating motor function through the """"""""indirect"""""""" striatal efferent pathway.

Project Start
1998-01-01
Project End
1999-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Andreassen, Ole A; Dedeoglu, Alpaslan; Stanojevic, Violeta et al. (2002) Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 11:410-24
Swerdlow, N R; Young, A B (2001) Neuropathology in Tourette syndrome: an update. Adv Neurol 85:151-61
Andreassen, O A; Ferrante, R J; Klivenyi, P et al. (2001) Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Exp Neurol 168:356-63
Orlando, L R; Alsdorf, S A; Penney Jr, J B et al. (2001) The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp Neurol 167:196-204
Augood, S J; Hollingsworth, Z R; Standaert, D G et al. (2000) Localization of dopaminergic markers in the human subthalamic nucleus. J Comp Neurol 421:247-55
Klivenyi, P; Andreassen, O A; Ferrante, R J et al. (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20:7-Jan
Dunah, A W; Wang, Y; Yasuda, R P et al. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57:342-52
Jenkins, B G; Klivenyi, P; Kustermann, E et al. (2000) Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 74:2108-19
Kuppenbender, K D; Standaert, D G; Feuerstein, T J et al. (2000) Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J Comp Neurol 419:407-21
Cha, J H; Frey, A S; Alsdorf, S A et al. (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354:981-9

Showing the most recent 10 out of 104 publications